The U.S. naloxone market consists of opioid overdose reversal drugs that can restore normal breathing to a person whose breathing has slowed or stopped as a result of overdosing on opioids. Naloxone is available in injectable and nasal spray forms, and works by blocking the effects of opioids on the brain and restoring breathing within two to eight minutes. The growing misuse of prescription painkillers and rising opioid overdose deaths have increased the need for widespread distribution of naloxone.

The Global U.S. Naloxone Market is estimated to be valued at US$ 1861.14 Mn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the U.S. Naloxone Market Companies are Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., Kern Pharma, S.L., Samarth Life Sciences Pvt. Ltd., Opiant Pharmaceuticals, Pfizer, Sandoz, and Amneal Pharmaceuticals. Key opportunities in the market include wider prescriptions and dispensing of naloxone through community-based programs and first responder kits. Technological advancements include the development of auto-injectable naloxone devices and alternate delivery forms like a powder nasal spray.

Market Drivers

The primary driver boosting the U.S. Naloxone Market Growth is the rise in opioid overdose cases and opioid epidemic in the country. As per the Centers for Disease Control and Prevention (CDC), opioid overdoses, especially due to synthetic opioids, increased by around 13% year-on-year from 2016 to 2017. The growing availability of illicit fentanyl and increasingly potent synthetic opioids have significantly contributed to rising overdose deaths. This has necessitated preventive measures and wider access to naloxone rescue kits. States have expanded naloxone access through public health programs to cater to high-risk populations and curb fatalities.

Get more insights on US Naloxone Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)